The ratings affirmation is based on several factors, including the health system’s strong liquidity position and continued market strength.
The outlook is stable, reflecting Moody’s Investors Service’s expectation the health system will maintain its balance sheet and achieve adequate operating performance comparable to its “A1”-rated peers.
More articles on healthcare finance:
S&P revises Orlando Health’s outlook to positive
S&P assigns ‘AA’ rating to CHOP’s bonds
Fitch assigns ‘AA’ rating to Duke University Health System’s bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
